Kwok-Kin Wong

Kwok-Kin Wong, MD, PhD, is an Associate Professor of Medicine at Dana-Farber Cancer Institute/Harvard Medical School and director of The Belfer Institute for Applied Cancer Science. Kwok-Kin Wong’s research activities focus on understanding the pathogenesis and genetic alterations involved in lung tumorigenesis, as well as testing novel lung cancer therapeutics in vivo. Toward this goal, Kwok-Kin Wong’s laboratory has generated multiple genetically engineered inducible mouse models of lung cancers based on recently discovered lung cancer relevant oncogenic mutations. These models have proved invaluable for understanding the molecular mechanisms of lung cancer initiation and progression, as well as for novel targeted therapeutic testings.

Kwok-Kin Wong was elected to the American Society of Clinical Investigation in 2007. He is a recipient of the Sidney Kimmel Foundation Scholar Award and the Tisch Foundation Solid Tumor Scholar Award. He was also the recipient of the Team Science Award from the American Association for Cancer Research in 2010.

After earning his MD and PhD from the College of Physicians and Surgeons at Columbia University, Kwok-Kin Wong completed his internship and residency in Medicine at Massachusetts General Hospital. He subsequently completed fellowship training in the Dana-Farber Cancer Institute/Massachusetts General Hospital combined program in Medical Oncology in 2001.

Kwok-Kin Wong is the Co-Founder at G1 Therapeutics, based in United States, North America. With a background in Biotechnology, Kwok-Kin Wong has a rich history of leadership and innovation.Kwok-Kin Wong studied Ph.D unknown at Columbia University. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.